Axcella Health Inc.: Nasdaq/NYSE listing notice — Axcella Health receives Nasdaq delisting notice for market value non-compliance

Axcella Health Inc.

Received Nasdaq notice Apr 3, 2023 for failing $15M MVPHS and $50M MVLS continued listing requirements.
Has 180 days until Oct 2, 2023 to regain compliance; must meet thresholds for 10 consecutive business days.
Also has prior bid price deficiency (below $1.00) with cure deadline of June 28, 2023.
May transfer to Nasdaq Capital Market if not cured; delisting possible if compliance not regained.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Axcella Health Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5450(b)(2)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(2)(C), 5450(b)(2)(A)

Exact text from the filing

April 3, 2023, Axcella Health Inc., (the “Company”) received written notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that (i) the Company was not in compliance with the requirement of a minimum Market Value of Publicly Held Shares (“MVPHS”) of $15,000,000 for continued listing on the Nasdaq Global Market, as set forth in Nasdaq Listing Rule 5450(b)(2)(C); and (ii) the Company was not in compliance with the requirement of a minimum Market Value of Listed Securities (“MVLS”) of $50,000,000, as set forth in Nasdaq Listing Rule 5450(b)(2)(A

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-23-043171

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.